---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-101074"
form_type: "8-K"
ticker: "MRNA"
cik: "0001682852"
company_name: "Moderna, Inc."
filed_at: "2022-04-11T23:59:59+00:00"
generated_at: "2026-06-26T08:15:09.110849+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Moderna appoints Jorge Gomez as CFO; David Meline to retire effective May 9, 2022

## Summary
- Jorge Gomez appointed CFO effective May 9, 2022, reporting to CEO Stéphane Bancel.
- Gomez previously CFO at Dentsply Sirona (Nasdaq: XRAY) and held CFO roles at Cardinal Health.
- Current CFO David Meline retiring; will serve as consultant through July 2024 with continued equity vesting.
- Gomez receives $700k base salary, $500k signing bonus, and equity grant valued at $4M vesting over four years.

## SEC filing metadata
- accession: 0001193125-22-101074
- form_type: 8-K
- ticker: MRNA
- cik: 0001682852
- company_name: Moderna, Inc.
- filed_at: 2022-04-11T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1682852/000119312522101074/0001193125-22-101074-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1682852/000119312522101074/d520384d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-101074
- JSON: https://secwatch.observer/filing/0001193125-22-101074.json
- Plain text: https://secwatch.observer/filing/0001193125-22-101074.txt

## Key facts
- Executive change
  Jorge M. Gomez was appointed as Chief Financial Officer at Moderna, Inc..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: On April 11, 2022, Moderna, Inc. (the “Company”) announced that Jorge M. Gomez had been appointed to serve as the Company’s Chief Financial Officer (“CFO”), beginning May 9, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1682852/000119312522101074/0001193125-22-101074-index.htm
- Executive change
  David Meline retired as Chief Financial Officer at Moderna, Inc..
  - Action: retired
  - Role: Chief Financial Officer
  source text: Following the appointment of Mr. Gomez, David Meline will retire as the Company’s CFO effective the same date, but will remain as a consultant to the Company to assist with the transition.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1682852/000119312522101074/0001193125-22-101074-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.